Delivery Order SPE2DB24D8003-SPE2DB25FJTZB
Award Date 3/12/25
Potential Completion Date 3/13/25
Potential Value $9.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $4,508.95, was issued by the Defense Logistics Agency (DLA) to prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of August 28, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program,...
- The U.S. Defense Logistics Agency (DLA) has awarded a Firm Fixed Price Delivery Order contract worth $6,681.60 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4563200640 - VRAYLAR 3 MG CAPSULE 30S. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Dakota Drug, Inc. The contract has an ultimate completion date of January 2, 2024 and does not...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of VRAYLAR 3 MG CAPSULE 30S. The firm-fixed-price contract has a ceiling value of $6,191.88 and a period of performance through February 25, 2025. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop Support Medical's ECAT...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $9,927.91 and a performance period extending to March 11, 2025. The contract was awarded on March 10, 2025 and is a firm fixed-price delivery order contract, without any set-aside designation. Dakota Drug, Inc. is a key supplier for...
- This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQWZ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $17,018.46, is a firm fixed-price delivery order for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at...
- This federal contract award, valued at $1,797.26, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of 4565441401 VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product, under a firm fixed-price delivery order. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to...
- This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQCC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,192.94 firm fixed price delivery order is for the provision of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. Dakota Drug, Inc. is a significant supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA...
- This is a delivery order for $2,762.65 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The order is for the pharmaceutical product Vraylar 4.5 mg capsule, with a performance period ending on April 9, 2024. The contract is a firm fixed-price arrangement without any set-aside designation. Dakota Drug, Inc. has over 20 years of experience as a prime contractor to the federal government, particularly the...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a potential value of $4,889.89 and a completion date of December 22, 2023. Under this contract, Dakota Drug, Inc. will provide the DLA Troop Support Medical with VRAYLAR 6 MG CAPSULE 30S, a pharmaceutical product. This delivery order is issued against Dakota Drug's existing blanket purchase...
- The Defense Logistics Agency (DLA) awarded a $12,321.87 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4,565,219,647 units of the prescription drug Vraylar 6 mg capsule. This delivery order contract is part of a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which seeks to procure commercial medical equipment,...